Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 2,360 shares at $13.01 ($31K) on 2020-11-20, disclosed to the SEC on 2020-11-24.
Scheduled sale ($31k) by VP, Qual, Reg, & Clin Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.01 | 366 | $5K | 15.3% |
| 2 | $13.17 | 1,994 | $26K | 84.7% |
| Total | $13.15 avg | 2,360 | $31K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-24 | $3K | — | Filing → |
| GNMK | SELL | 2021-02-22 | $6K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |